73 related articles for article (PubMed ID: 18758502)
41. The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis.
Swigris JJ; Brown KK
BioDrugs; 2010 Feb; 24(1):49-54. PubMed ID: 20055532
[TBL] [Abstract][Full Text] [Related]
42. Combination of Endothelin-1 (ET-1) and L-NAME to Induce Murine Focal Cortical Stroke with Persistent Sensorimotor Deficits.
Lui M; Gouveia A; Lagace D; Wang J
Methods Mol Biol; 2022; 2515():75-87. PubMed ID: 35776346
[TBL] [Abstract][Full Text] [Related]
43. A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block.
Alvarez D; Briassouli P; Clancy RM; Zavadil J; Reed JH; Abellar RG; Halushka M; Fox-Talbot K; Barrat FJ; Buyon JP
J Biol Chem; 2011 Sep; 286(35):30444-30454. PubMed ID: 21730058
[TBL] [Abstract][Full Text] [Related]
44. Endothelin-1 as initiator of epithelial-mesenchymal transition: potential new role for endothelin-1 during pulmonary fibrosis.
Kim KK; Chapman HA
Am J Respir Cell Mol Biol; 2007 Jul; 37(1):1-2. PubMed ID: 17575081
[No Abstract] [Full Text] [Related]
45. Fos-related antigen-1 transgenic mouse as a model for systemic sclerosis: A potential role of M2 polarization.
Yasuoka H; Tam YYA; Okazaki Y; Tamura Y; Matsuo K; Feghali-Bostwick C; Takeuchi T; Kuwana M
J Scleroderma Relat Disord; 2019 Jun; 4(2):137-148. PubMed ID: 35382387
[TBL] [Abstract][Full Text] [Related]
46. [Pulmonary cirrhosis; pathology of elastic fiber system].
BRANDENBURG W
Zentralbl Allg Pathol; 1954 Jan; 91(4-5):151-61. PubMed ID: 13170509
[No Abstract] [Full Text] [Related]
47. Lecru L, Desterke C, Grassin-Delyle S, et al. Cannabinoid receptor 1 is a major mediator of renal fibrosis. Kidney Int. 2015;88:72-84.
Kidney Int; 2017 Oct; 92(4):1018. PubMed ID: 28938941
[No Abstract] [Full Text] [Related]
48. Erratum to "factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study".
Inghilleri S; Morbini P; Campo I; Zorzetto M; Oggionni T; Pozzi E; Luisetti M
Pulm Med; 2011; 2011():515608. PubMed ID: 21876798
[No Abstract] [Full Text] [Related]
49. Knowing a name promotes cooperation.
Tan C
Science; 2017 Mar; 355(6332):1386-1387. PubMed ID: 28360304
[No Abstract] [Full Text] [Related]
50. Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension.
Tabeling C; González Calera CR; Lienau J; Höppner J; Tschernig T; Kershaw O; Gutbier B; Naujoks J; Herbert J; Opitz B; Gruber AD; Hocher B; Suttorp N; Heidecke H; Burmester GR; Riemekasten G; Siegert E; Kuebler WM; Witzenrath M
Front Immunol; 2022; 13():895501. PubMed ID: 35757687
[TBL] [Abstract][Full Text] [Related]
51. Effect of nitric oxide deficiency on the pulmonary PTHrP system.
Brockhoff B; Schreckenberg R; Forst S; Heger J; Bencsik P; Kiss K; Ferdinandy P; Schulz R; Schlüter KD
J Cell Mol Med; 2017 Jan; 21(1):96-106. PubMed ID: 27581501
[TBL] [Abstract][Full Text] [Related]
52. Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.
Gonzalez-Cadavid NF; Rajfer J
Nat Rev Urol; 2010 Apr; 7(4):215-21. PubMed ID: 20212516
[TBL] [Abstract][Full Text] [Related]
53. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE
J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849
[TBL] [Abstract][Full Text] [Related]
54. Cell-type specific interaction of endothelin and the nitric oxide system: pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-transgenic mice.
Slowinski T; Kalk P; Christian M; Schmager F; Relle K; Godes M; Funke-Kaiser H; Neumayer HH; Bauer C; Theuring F; Hocher B
J Physiol; 2007 Jun; 581(Pt 3):1173-81. PubMed ID: 17395629
[TBL] [Abstract][Full Text] [Related]
55. [Nitric oxide and endothelins in pulmonary hypertension].
Aoki Y; Saji T
Nihon Rinsho; 2001 Jun; 59(6):1059-64. PubMed ID: 11411113
[TBL] [Abstract][Full Text] [Related]
56. Endothelin in pulmonary fibrosis.
Fonseca C; Abraham D; Renzoni EA
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):1-10. PubMed ID: 20448055
[TBL] [Abstract][Full Text] [Related]
57. Pulmonary fibrosis in L-NAME-treated mice is dependent on an activated endothelin system.
Kalk P; Mach A; Thone-Reineke C; Godes M; Heiden S; Sharkovska Y; von Websky K; Relle K; Hocher B
Can J Physiol Pharmacol; 2008 Aug; 86(8):541-5. PubMed ID: 18758502
[TBL] [Abstract][Full Text] [Related]
58. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
